MTOR and neoplasm: As for mTOR, its enhanced expression (≥2 scores) was not significantly correlated with any clinicopathological parameters such as tumor grade, stage, size, metastasis, survival rate, patients’ sex or age (P > 0.05), which was also observed in previous study (Rausch et al., 2019).